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ABSTRACT
The objective of the study is to perform an integrated analysis of microbiological risks and
nutritional benefits in a fish product, Cold Smoked Salmon (CSS).
Literature study identified the major health risks and benefits in connection with CSS
consumption. The reduction of the risk of Coronary Heart Disease (CHD) mortality and
stroke, as well as enhanced cognitive (IQ) development of unborns following maternal
intake, are identified as the main health benefits of omega-3 fatty acid from CSS. Contrary,
risk of meningitis, septicemia and abortion/stillborn are identified as a major health risk
endpoints due to exposure to the pathogen L. monocytogenes.
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Two consumption scenarios were considered: a reference scenario (23g/day and 20g/day
for man and woman respectively) and an alternative scenario (40g/day for both sexes). In
order to evaluate and compare the risks and benefits, the Disability Adjusted Life Years
(DALY) method has been used as a common metric.
Results show that the overall health benefits outweigh the risk, foremost contributed by the
effect of decreased CHD mortality and IQ increase. A sensitivity analysis indicated that
this result was robust for the analyzed parameters, except the storage time: the adverse
effect of consumption of CSS prevails over the beneficial effect if the storage time of CSS
is increased from two weeks to five weeks or more, due to an increased risk of listeriosis.
This study demonstrates how microbial risks can be integrated in risk-benefit assessment,
and shows that a sensitivity analysis has an added value, even if the benefits largely
outweigh the risk in the initial analysis.
Keywords: Cold-smoked salmon; Listeria monocytogenes; omega-3 fatty acids; DALY.
1. INTRODUCTION
Risk-benefit assessment is the weighing of the probability of an adverse health effect against
the probability of a beneficial effect as a result of exposure/intake of food (EFSA, 2010).
Examples and a guidance of how to perform risk-benefit assessment of foods have recently
been provided (Hoekstra et al., 2010; EFSA, 2010). Nonetheless, risk-benefit methods need
further development. There is currently no internationally agreed method to perform human
health risk-benefit assessment of food and so far only a few risk-benefit assessments
studies included microbiological hazards (Havelaar et al., 2000; Magnússon et al., 2012).
Typical aspects of microbiological risk assessment, like the inclusion of the impact of storage
and processing on the weighing of the risk and benefit, are therefore rarely included in
published risk-benefit assessments.
In this paper we present a risk-benefit assessment on a fish product. Several studies have
assessed the risk of toxic contaminants and benefits of nutrients following the consumption
of  fish (Gladyshev et al., 2008; Cohen et al., 2005b; Guevel et al., 2008; FAO/WHO, 2011;
Hoekstra et al., 2012) and found that in general the public health benefits are larger than the
risks. However, microbial risks have not been integrated into these risk-benefit assessments.
The present study aims to illustrate how a microbiological hazard can be included in a typical
risk-benefit assessment and how this may add to the existing risk-benefit assessment tools
and methodologies. Furthermore, we included a sensitivity analysis to evaluate the impact of
some of the model parameters on the assessment.
2. RISK-BENEFIT ASSESSMENT OF COLD-SMOKED SALMON: MODEL
2.1 Scope
The risk of the bacterial pathogen (L. monocytogenes) is evaluated against the benefits of
the intake of omega-3 fatty acids in a risk-benefit assessment of CSS consumed in
Denmark. Salmon is an oily fish containing considerable amount of omega-3 fatty acids, it is
a popular ready-to-eat food in most part of the world and it is consumed in many European
countries (WHO/FAO, 2004).
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The assessment compares a reference scenario with an alternative scenario, as in
(Hoekstra et al., 2010). In this comparison it is assumed that CSS is added to the normal diet
in an isocaloric way and substitution by other food items with potential health effects is
neglected. Best estimates are applied for the various model parameters. Disability Adjusted
Life Years (DALYs) are used as an integrated health measure to compare risks and benefits
(Hoekstra et al., 2010).
All statistical and mathematical modelling is implemented in Microsoft Office, version 2007
except for the dose-response modelling of CHD mortality and stroke (Appendix) which was
performed on statistical software R, version 2.10.1.
2.2 Hazard Identification, Selected Health Effects and Affected Subpopulation
Cold-smoked fish products may be contaminated with L. monocytogenes, the agent that
causes foodborne listeriosis. Vacuum-packed cold-smoked fish has a long shelf-life and can
support the growth of L. monocytogenes (WHO/FAO, 2004). The contribution of salmon for
the cases of listeriosis has been reported (Pouillot et al., 2007; Lindqvist and Westoo, 2000;
WHO/FAO, 2004). Recently an increasing incidence of invasive listeriosis, primarily
septicemia and meningitis have been reported in several European countries (Allerberger
and Wagner, 2010; Jensen et al., 2010). Listeriosis during pregnancy is also a serious threat
to the unborn child, which can lead to abortion/ stillborn (Smith, et al., 2009). Hence,
meningitis, septicemia and abortion/stillborn are selected as the endpoints following
exposure to L. monocytogenes.
Elderly, immunocompromized and pregnant women and/or their unborn fetuses are the most
susceptible groups for listeriosis (WHO/FAO, 2004; Allerberger and Wagner, 2010).
Therefore, both sexes aged ≥ 60 are selected for septicemia and meningitis. The population
of interest for abortion/stillborn, are potentially pregnant women aged 20-45.
2.3 Benefit Identification, Selected Health Effects and Affected Subpopulation
The nutrients in fish that have plausible and significant health benefits for human are omega-
3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexanoic acid (DHA)
(Mozaffarian, 2006). Intake of fish may protect against CHD mortality and stroke
(Mozaffarian, 2006). In addition, an association is found between the maternal intake of DHA
and a beneficial effect in cognitive development of their unborn child, measured as an
increase in IQ (Cohen et al., 2005a). Zeilmaker et al. (2012) investigated both the adverse
(MeHg) and beneficial (DHA) effect of fish intake on IQ and found a very small IQ gain for
salmon intake. Therefore, reduction of CHD mortality and total stroke, and improved
cognitive development are selected endpoints in this paper.
Most of the studies mentioned in the Appendix (Table 8 and 9), which are incorporated in the
dose-response modeling of CHD mortality and total stroke, included adults of both sexes
older than 35 years. Hence, both sexes aged ≥ 35 are selected for both endpoints as a
target population. For the benefit of maternal intake of DHA on the child’s IQ, it is assumed
that women aged 20-45 give birth with different probabilities depending on age (Table 3).
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2.4 Intake and Exposure Assessment
The current mean fish intake is 20 and 23 g of fish/day for women and men respectively
(Pedersen et al., 2010). In the reference scenario it is assumed that every individual
consumes the current mean fish consumption as CSS i.e. 20 and 23 g for women and men.
For the alternative scenario it is assumed that every person consumes 40 g CSS/day. The
intake of CSS is assumed the same for all age groups in each scenario.
Omega-3 fatty acid intake is computed from the official Danish Food Composition Database
in combination with the consumption scenarios (Denmark Technical University, 2011).
For L.monocytogenes, an exponential growth model is applied to assess the distribution of
concentrations at consumption as a function of initial concentration, storage time, growth
rate and lag-time (Table 1, eq. 7). The 10-based logarithm of initial concentrations (N0) of
L.monocytogenes {0.5: 1.5: 2.5: 3.5} and their prevalences {0.28: 0.05: 0.01: 0} are taken
from Jørgensen and Huss (1998). For the exposure assessment, these results are combined
with the consumption scenarios.
2.5 Integration of the Health Effects
To combine the health outcomes of the risk and the benefit we have chosen the DALY
model of (Hoekstra et al., 2010). For an individual of age CA, the amount of DALY per
person per year is:
DALYa,s=Peff,a,s[(Prec*YLDrec*w+Pdie(YLDdie*w+LEa,s-CA-YLDdie)+(1-Pdie-Prec)*(LEa,s-CA)*w]
Where:
DALYa,s disability adjusted life years at age, a and sex, s
Peff,a,s probability of onset of the disease at age, a and sex, s, per year
Prec probability of recovery from the disease
Pdie probability the disease causes death
YLDrec duration of disease for those who recover
YLDdie duration of disease for those who die
CA current age of individual in year of disease onset (years)
LEa,s normal life expectancy for an individual of age CA1
w disability weight for disease.
2.6 Dose-Response Relationship
After a literature survey, eleven and eight studies are incorporated for the dose-response
modeling of CHD mortality and total stroke respectively (Appendix, Tables 8 and 9). The
results from studies that are included in the dose-response relation of CHD mortality and
total stroke have been implemented by a relation where the relative risk (RR) of the health
outcomes is a function of fish intake. Different functions are analyzed in order to select the
best model based on the best fit statistics (Appendix 1).
1 LE is interpreted here as expected age at death not as the also  commonly used expected
remaining years of life
European Journal of Food Research & Review, 2(2): 49-68, 2012
53
Table 1. Model equations applied and point estimates of the parameters
Model equation Parameter values Description (unit)
1. IDHA = Fintake * DHA Fintake, scenarios
DHA = 1.16g/100g
IDHA, intake of DHA (g/d); Fintake, fish intake
(g/d); DHA content of CSS (g DHA per g
CSS) (DTU, 2011).
2. ΔIQ = d*IDHA
(Cohen et al. 2005a)
d = 1.3, uncertainty
interval (0.8-1.8)
ΔIQ, change in intelligent quotient; d,
coefficient.
3. Peff(IQ) = Probability of a
woman giving a birth,
Peff(IQ), vary
depending on age of
a women giving a
birth
Peff(IQ), probability of onset of IQ  effect which
is equivalent to probability of a woman giving
a birth (Table 3).
4. ln(RR) = a + b* ln(Fintake) RR, a=0.17, b=0.137
for CHD mortality
and a=0.113,
b=0.094 for stroke
RR, relative risk of CHD mortality and total
stroke; a and b are estimated in the meta-
analysis in appendix1.
5. Peff,ep,r (a,s) = Inc(a,s)/N(a,s) Variable with age a,
sex s and endpoint
ep
Peff,ep,r(a,s) probability of onset of endpoints
ep, (CHD mortality and total stroke) at
reference intake r, in 5 year age class a, for
sex s; Inc(a,s), current incidence of endpoint
ep in (a,s); N(a,s), number of population in
(a,s). Note: It is assumed that the probability
of effect is the current incidence rate for
reference intake for both endpoints.
6. Peff,ep,a(a,s) =RR(s)a Peff, ep,r
(a,s) /RR(s)r
Varies with
scenarios, ages and
sexes
Peff,ep,a(a,s), probability of onset of endpoint at
alternative intake at age and sex; RR(s)a,
relative risk of alternative scenario at sex, s;
RR(s)r, relative risk of reference scenario at
sex, s.
7. logNt = logN0 + μ(t – λ) N0, (see section 2.4),
t=14; μ=0.113;
λ=0.167 (WHO/FAO,
2004)
Nt, concentration of Listeria after storage
(CFU/g); N0, initial concentration (CFU/g); μ,
growth rate (log CFU/d); t, storage time
(day); λ, lag-time (day). At storage
temperature of 5ºC
8. Dlisteria = Fintake * Nt Dlisteria, dose of listeria (CFU/d).
9. Pinf = 1-e-rDlisteria r= 5.85 * 10-12 Pinf, probability of infection and illness of
Listeria; r, dose-response parameter specific
to Listeria for susceptible population
(WHO/FAO, 2004).
10. Peff(mengi) = Kmengi * Pinf K = 0.24 Peff(mengi), probability of onset of meningitis;
Kmengi, proportion of meningitis cases among
those infected with Listeria.
11. Peff(septi) = Ksepti * Pinf Ksepti = 0.74 Peff(septi), probability of onset of septicemia; K
septi, proportion of septicemia cases among
those infected with Listeria.
12. Peff(abo/stl) = K(abo/stl) * Pc *
Pinf
K(abo/stl) = 0.266; Pc,
variable with age
Peff(abo/stl), probability of onset of
abortion/stillborn; Kabo/stl, proportion of
abortion/stillborn among pregnant women
infected with Listeria. Pc, probability of giving
birth
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In addition, the models are validated using residual analysis and QQ-plot (Ekstrøm and
Sørensen, 2011). Based on this, the log-linear model has been selected to estimate the RR
based on the intake scenarios. Then, the estimated RR are converted into absolute risk by
combining the RR’s and the current incidence rates of CHD mortality and total stroke, which
are obtained from Denmark Statistics (2011). To characterize the benefit of maternal DHA
intake to the cognitive development (IQ) of their offspring, the relation described in Table 1,
eq. 1 is applied.
The exponential dose-response model for L. monocytogenes is used to characterize and
estimate the probability of infection (Table 1, eq. 9).
The DALY calculation has been performed for each sex, age and scenario. From these, the
total DALYs are calculated for the Danish population by summation; population’s data are
shown in Table 2 and obtained from Denmark Statistics (2011). Parameter estimates for
DALY computation are also presented in Table 5 and explained in sections 2.7 and 2.8.
Table 2. Number of population by age and gender (Denmark Statistics, 2011)
Sex
Man Woman Total
Age ≥ 60 582589 642706 1225295
18-49 1155573 1155573
≥ 35 1556888 1631905 3188793
5569661
2.7 Estimation of DALY Parameters for Listeriosis
The probability of developing septicemia (Peff(septi)) and meningitis (Peff (mengi)) depends on the
infection probability, Pinf, which depends on fish intake. In the reference scenario Pinf is
8.9*10-6 for women (20g CSS) and 1*10-05 for men (23 g CSS. In the alternative scenario (40
g CSS) it is 1.78*10-05. In this study it is assumed that the percentage of septicemia and
meningitis (Ksepti, Kmengi) is 74% and 24% respectively (Gerner-Smidt et al., 2005). Studies
reported that the percentage of abortion/stillborn (Kabo/still) is about 15-25% (Mylonakis et al.,
2002) and 33.3% (Smith et al., 2009). Consequently, we take the mean (26.6%) of the two
reported percentages to estimate the abortion/stillborn percentage.
Pdie is assumed to equal published case fatality rates, 20.8% and 25.4% of the patients died
of septicemia and meningitis respectively within a month of diagnosis in a 10-years follow up
study period (Gerner-Smidt et al., 2005). For septicemia it is assumed that people who do
not die will recover, so Prec = 1- Pdie. For meningitis the sequela is taken into account, so Prec
= 1- Pdie -0.14 (Aouaj et al., 2002).
YLDdie is computed for meningitis and septicemia from (Gerner-Smidt, et al., 2005). YLDrec
and w for both meningitis and septicemia are obtained from (Kemmeren et al., 2006).
Abortion/stillborn implies that the life of a newborn is lost. Therefore, YLDdie, YLDrec, CA and
Prec are 0 and Pdie is 1.Obviously abortion/stillborn can only happen with pregnant women
therefore the probability of a pregnancy, Pc is included and Peff(abo/stl) is estimated using eq.
12 on Table 1. It is assumed that women give birth with different probabilities depending on
age. The probabilities of pregnancy at age below 20 and above 45 are assumed zero.
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Table 3. The annual probability that a woman gives birth depending on age (Denmark
Statistics, 2011)
Age mother Pc, Probability
of giving birth
20 - 25 year 0.039
25 - 30 year 0.1139
30 - 35 year 0.127
35 - 40 year 0.057
40 - 45 year 0.01
2.8 Estimation of DALY Parameters for CHD Mortality, Stroke and IQ
The case fatality rate of total stroke is assumed to be the same as for ischemic stroke, so
Pdie=0.26 (Andersen et al., 2009). Prec and YLDrec are set to zero, assuming no one can
recover from stroke. We also assumed that the YLDdie is associated with highest mortality
period which is within 30 days, this leads to an estimate of approximately 0.082 (Ingall, 2004;
Andersen et al., 2009). The disability weight of stroke varies depending on the stages of
stroke. WHO estimated that for the first-ever stroke cases and long-term stroke survivors, w
is 0.92 and 0.266 respectively (WHO, 2008). In our case, we take the rounded mean of the
two values (w=0.6). Peff depends on RR, age and sex (eq. 4 in Table 1). RR for stroke for 20,
23 and 40 g fish/day is 0.84, 0.83 and 0.79.
For fatal CHD, because no one recovers from fatal CHD, Prec and YLDrec are set to 0. By
definition Pdie of fatal CHD is 1. Peff depends on RR and age and sex (eq. 4 in Table 1). RR
for fatal CHD for 20, 23 and 40 g fish/day is 0.79, 0.77 and 0.71 respectively.
For IQ, Peff(IQ) is assumed to be the probability that a woman delivers a baby (Pc, Table 3).
The probability of having a particular IQ (from the definition of IQ, normal distributed, mean
100, standard deviation 15) resulting from the change in IQ obtained from Table 1 eq. 2
linked with the disability weight of a particular IQ (Table 4) results in a weighted average w
depending on IQ change as in (Hoekstra et al., 2012). For the IQ effect, the parameters
YLDdie, YLDrec, Pdie, Prec and CA are 0.
Table 4. Disability weights of IQ levels (Stouthard et al., 1997)
IQ W
>85 0
70-84 0.09
50-69 0.29
35-49 0.43
20-34 0.82
0 <20 0.76
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Table 5. Parameter values for the DALY calculations as estimated from
epidemiological data
Health effects Estimated parameters
Prec YLDrec Pdie YLDdie W
Meningitis 0.625 0.5 0.254 0.08 0.32
Septicemia 0.792 0.02 0.208 0.08 0.93
Abortion/stillborn 0.0 - 1 - -
CHD mortality 0.0 - 1 - -
Total stroke 0.0 - 0.26 0.082 0.6
IQ 0.0 - 0.0 - X *
X* is dependent on IQ (Table 4) which depends on the maternal intake of DHA (Table 1 eq 2).
The net DALY is calculated using:
ΔDALY = ∑DALYalt - ∑DALYref
Where, ΔDALY is change in DALY; ∑DALYalt, summation over all persons in the population
of DALY’s for the alternative scenario; ∑DALYref, summation over all persons in the
population of DALY’s for the reference scenario.
DALY represents health loss; therefore, if the estimation of ΔDALY results in a positive value
then the change in consumption has an adverse health effect. If the ΔDALY is negative, then
the change in consumption has a beneficial effect (Hoekstra et al., 2010).
2.9 Sensitivity Analysis
A sensitivity analysis is performed to explore the impact of modifying some of the model
parameter estimates on the risk-benefit assessment. Targeted parameters are the d-value
for the effect of DHA intake on IQ change (Table 1, eq. 2), the parameters a and b defining
RR of CHD and total stroke (Table 1, eq. 4), the storage time t (Table 1, eq. 7) and the lag-
time of L. monocytogenes, λ (Table 1, eq. 7). These parameters relate to different endpoint
and are known to be variable and/or uncertain. Moreover, for the estimation of RR of CHD
mortality and total stroke one more function (exponential function, ln(RR)= b* Fintake is
analysed to see the difference in DALY estimate of the two endpoints compared to the DALY
estimate obtained from function, ln(RR)= a + b*ln( Fintake).
For example, the storage time of CSS was wide in range in various studies (Hansen et al.,
1998; Leroi et al., 2001; WHO/FAO, 2004). L.monocytogenes relative lag time in foods is in
the range of 0–40h, with a peak value near 2.5. Lag-times in laboratory broths had a similar
range, but the peak value was nearer to 4.5h (Ross, 1999). In this study 4h is selected as a
baseline lag-time value and converted to day unit (Table 1, eq. 7) and for the sensitivity
analysis 2.5h and 4.5h is used from the peak value of foods and laboratory broths.
Furthermore, the uncertainty interval of the d-value in Table 1, eq, 2 and the 95% CI of the
selected (bold) function in the appendix on Table 10 for the parameter a and b of RR of both
CHD mortality and stroke are analyzed for sensitivity. The sensitivity analysis is done by
varying one variable at the time (OAT) while keeping the others constant at their baseline
value. More sophisticated sensitivity methods are possible (Saltelli et al., 2000), but in this
relatively simple model the OAT approach is sufficient to identify the greatest sources of
uncertainty and their approximate influence on the end result.
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3. RISK-BENEFIT ASSESSMENT OF COLD-SMOKED SALMON: RESULTS
3.1 Baseline
The assessment shows that increasing the consumption of CSS has an overall health gain
with respect to the selected endpoints, as the beneficial effects of fatty acids clearly
outweigh the adverse health effect of Listeria (Table 7).
The extra cases of the hazardous endpoint and the prevented cases of the beneficial
endpoint due to the change in consumption are presented in Table 6 below.
Table 6. The number of extra/prevented cases when change in consumption per year
Endpoints Reference Alternative Extra/prevented
cases
Septicemia 8.66 16.2 7.54
Meningitis 2.83 5.25 2.42
Abortion/stillborn 1.5 3 1.5
CHD mortality 5435 4953 -482
Stroke 3787 3580 -207
The number shows the number of cases per year at the different scenario. The last column
shows that the additional cases (positive value) due to listeriosis and the prevented number
of cases (negative value) due to omega-3 fatty acid when change in consumption.
When comparing the hazardous endpoints, for listeriosis there are more life years lost due to
septicemia and meningitis in women compared to men. This is due to a larger increase in
intake of CSS for women compared to men. The amount of healthy life years lost is largest
for septicemia, followed by abortion/stillborn and meningitis.
Table 7. The baseline DALY’s for each sex and scenario
Men Women
Ref Alt ΔDALY Ref Alt ΔDALY Sum of
DALY
Septicemia 13 23 9.7 14.6 29 14.5 24.
Meningitis 6 10.6 4.5 6.74 13.5 6.8 11
Abortion/Stillborn* 11 23 12 12
CHD mortality 32093 29592 -2501 23402 21032 -2370 -4871
Stroke 11874.7 11302 -572 15192.5 14284 -908 -1480.5
IQ* -3139 -6181 -3042 -3042
Net DALY -9343
Ref, reference scenario; Alt, alternative scenario
*Because abortion/stillborn and IQ endpoints are result of maternal consumption on their fetus, the
DALY is only reported for women.
On the other hand, there is a large gain in healthy life years for both sexes due to reduction
of CHD mortality and stroke. Likewise, a large benefit is obtained due to the IQ effect.
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Women achieve more benefit than men by the prevention of stroke and men attain more
benefit from the prevention of CHD mortality than women.
As a result, the net public health effect of the change of consumption of CSS leads to a gain
of 9343 healthy life years in the population of approximately 5570000.
3.2 Sensitivity Analysis
The sensitivity analysis shows quantitative and qualitative changes in ΔDALY depending on
theparameters. As illustrated in Fig. 1, increasing the storage period  leads to higher risks of
listeriosis and has no effect on fatal CHD, stroke and IQ change in newborns. The net DALY
shows that the adverse effect of consumption of CSS prevails over the beneficial effect from
five weeks of storage time on. It leads to a loss of 1677 and 58391 healthy life years in the
population at five and six weeks storage period respectively.
2 weeks, 4 weeks, 5 weeks, 6weeks
Fig. 1. Sensitivity analysis for the effect of storage time.
The sensitivity analysis for the RR for CHD mortality and total stroke, lag-time of listeria and
the d-value uncertainty interval shows no change in the overall balance of the risk-benefit.
The result of all the parameters analysed for sensitivity is presented in Fig. 2 below,
including the net DALY when using the exponential RR model of CHD mortality and total
stroke as an alternative model. The figure includes the net DALY for the baseline scenario
given in Table 7, which is represented by “baseline”. The various parameters and their
values that are used to estimate the baseline net DALY are presented in Table 1.
In Fig. 2 it appears that there is no difference between the resulst of the lag-time sensitivity
analysis and the baseline result. The other parameters (RR and d) show a beneficial effect
of net DALY which is similar to baseline result qualitatively. However, there can be seen a
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shift of beneficial to hazardous effect at which the bar extends to the positive direction at
storage time of 5 weeks and further.
Fig. 2. Result of sensitivity analysis for all selected parameters
When using the exponential function (ln(RR)=  b* Fintake) the predicted DALY decrease to -
5580 and -1964 for CHD mortality and total stroke respectively compared to the DALY
estimate obtained by ln(RR)= a + b*ln( Fintake) (Table 7).
4. DISCUSSION
4.1 The CSS Study
In this study with CSS, major health benefit is obtained from the prevention of CHD mortality
and the IQ increment of newborns. This is in accordance with other studies on fish
consumption and/or omega-3 fatty acid intake (Cohen et al., 2005b; Guevel et al., 2008;
Hoekstra et al. 2012). In Hoekstra et al. (2012) the health benefit was higher for stroke than
IQ effect, in this study the health benefit is higher for IQ than stroke. This may be related to
the difference in dose-response model used for stroke and because salmon is an oily fish
that have a significant effect on IQ. As a part of sensitivity analysis the dose-response model
used by Hoekstra et al., (2012) for stroke is applied to see the difference and the outcome
indicate that the benefit would step up but still the health benefit is higher for IQ gain than for
stroke.
Our paper is the first that shows that these health benefits also outweigh the risk of
listeriosis, unless the storage time is too long (>4 weeks) and leads to the exposure to high
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concentrations of the pathogen. Note though that if abortion was valued less severe than in
our analysis storage time can be longer before risks outweigh benefits.
As common in microbiological risk assessment, different parameters (storage time, lag-time,
growth rate, etc) that affect the concentration of the pathogen have been considered in the
exposure assessment of L. monocytogenes. However, in the intake assessment of omega-3
fatty acid, the different parameters that affect its concentration have not been considered in
the same way. For instance, processing and storage of CSS, and the biovailability of the
compound could affect its  concentration before it reaches to target organ. In a comparative
approach of the microbial risk and the nutritional benefit, the exposure assessment for
nutrients and chemical contaminants should consider all the factors that affect the
concentration until the compound in question reaches the target organ to exert an action.
The dose-response models that are applied for CHD mortality and stroke used aggregate
data and different models have been used and validated to optimize the output.
Nevertheless, the conversion of the estimated RRs to absolute risk is associated with
uncertainty (Table 1, eq. 5 and 6). On the other hand, a few aggregate data have been used
to model the dose-response relationship of the hazardous endpoints. In addition, in this
study the intake assessment uses a point estimate of CSS and DHA intake for all age
groups but take into account the differences between sexes. These all together might have
an impact on the final outcome.
The result is expressed in DALY (morbidity, mortality and recovery) and it appears that, the
septicemia to meningitis DALY ratio is approximately 2:1 (Table 7). Compared to men, the
DALY changes are higher for women for both septicemia and meningitis cases this could be
linked to the increase in intake of CSS on women than men. Looking back the history of
invasive listeriosis in Denmark, in most cases men have higher incidence of invasive
listeriosis than women (Gerner-Smidt et al. 2005). Septicemia has been the highest
morbidity compared to meningitis. On the other hand, the mortality rate is higher for
meningitis than septicemia (Gerner-Smidt et al. 2005). However, mostly in comparative
studies on overall invasive listeriosis (septicemia vs meningitis), the ratio of septicemia to
meningitis is 5:1 (Jensen et al., 2010); 3:1 (Gerner-Smidt et al. 2005).
In this study four parameters have been tested for sensitivity. The most sensitive parameter
was the storage time. The shift of a net public health benefit to a net public health risk is
observed when CSS is consumed at five weeks of storage and further (Fig. 2). The shift is
mainly because of the increased concentration of L.monocytogenes that entails increased
incidence of listeriosis. According to our model prediction, maximum benefit with minimum
risk can be attained from the consumption of CSS within two weeks of production. The risks
increase with storage time whereas benefits remain unchanged. Further study may
encompass stochastic analysis of all the uncertain parameters presented in the study.
The study was not meant to thoroughly address all beneficial and hazardous components;
neither includes the all related endpoints in connection to CSS consumption. Instead, focus
was on the integration of microbial hazards and nutritional benefits. Although there could be
more endpoints due to the intake/exposure of the selected risk and benefit, this paper
assess health outcomes with strong evidences that enable quantitative evaluation. In
addition, we evaluated only endpoints that we expected to have relatively high public health
impact. For example, febrile gastroenteritis is usually caused by L. monocytogenes
(WHO/FAO, 2004); but reported quantitative data with respect to this endpoint are
insufficient to do a risk-benefit assessment and moreover, febrile gastroenteritis has less
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public health impact than septicemia and meningitis. Thus, febrile gastroenteritis is not
considered in this assessment. Other health effects related to fish/omega-3 fatty acid intake,
for instance neuropsychiatric disorders (Young and Conquer, 2005) are not considered for
the same reason. If our study would have included chemical hazards as well (dioxin-like
compounds and mercury) and would have included all the endpoints, the net DALY would
change quantitatively, and the balance between risk and benefit might change as well.
4.2 Implications for Future Risk-Benefit Assessment Methodology
If a pathogen is selected as a hazard, it is essential that the specific associated endpoints
are considered instead of considering the generic clinical syndrome. Nevertheless, most
Quantitative Microbial Risk Assessments (QMRA) report the generic clinical syndrome cases
only. For example, if the assessment includes listeria then the endpoint is cases of listeriosis
(Pouillot et al., 2007; Lindqvist and Westoo, 2000; WHO/FAO, 2004). However, these types
of data are insufficient if one intends to integrate pathogens in risk-benefit assessment
because of the exclusion of the mortality, morbidity, recovery and/or sequela of the specific
diseases. In this risk-benefit assessment, the specific major clinical syndromes of foodborne
listriosis (meningitis, septicemia and abortion/stillborne) are included, instead of the generic
endpoint “cases of listeriosis”. On the other hand, this could also be a problem in dose-
response modeling as most studies on the pathogenesis of pathogens have dose-response
parameters only for general cases like listeriosis, salmonelosis, campylobacteriosis. In this
case, different epidemiological data could be used to extrapolate the percentage of the
specific endpoints as in section 2.7.
In addition, the integration of the health effects of microbial hazard into risk-benefit
assessment may need further refining in the distinction of pathogenesis from the pathogens
itself and the microbial toxins especially with regard to exposure assessment and dose-
response modeling. Depending on the pathogens/toxins, the exposure assessment and the
dose-response relationship require additional investigation like for example the stomach and
small intestine dynamics as explained by (Pielaat et al., 2005) for Bacillus cereus.
Moreover, in this study the DALY is used as a common health metric to integrate microbial
hazard in risk-benefit assessment.  Here a thorough quantitative assessment has been done
to the end, as opposed to the EFSA, 2010; Hoekstra, et al., 2010) where the assessment
stops when the benefit outweighs the risk or vice versa. Had we followed the tiers of BRAFO
tiered approach (Hoekstra et al., 2010) in this study, we might have stopped at the earlier
stage. For example, in our assessment the baseline result showed that, the benefit clearly
outreaches the risk (Table 7); as of Hoekstra, et al., (2010), we could have stopped at this
point. However, further quantitative analysis gives a different result in connection with the
change in storage time of CSS (Fig. 1), which, in our view, is an important result. This shows
that the integration of microbial risk and/or benefit into risk-benefit assessment may require a
more elaborate quantitative assessment to reach to best estimation of public health impact.
Furthermore, in general some disease may have some major secondary disease (sequela)
that result from the primary clinical syndrome. For instance, if someone gets liseriosis
meningitis then there is some probability that person would get neurological sequela (Aouaj
et al., 2002).  The DALY model applied in this study does not consider this kind of endpoints.
However it can be extended to do so easily.
Consequently, the current risk-benefit assessment framework/models need more refinement
in regard to the aforementioned points.
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5. CONCLUSION
This paper evaluated and integrated the major risk and benefits in connection with the
change in CSS consumption. Our risk-benefit assessment predicted that the overall health
impact of change in consumption of CSS from reference to alternative intake provide more
health benefits for the Danish population.
The model predictions depend on the assumptions taken during the analysis and the
sensitivity analysis reveals that the most sensitive parameter was the storage time.  If CSS is
consumed after two weeks of storage, the benefit remains the same but the risk increases
significantly with storage time.
This study provides an insight for future improvement of the methodologies with regard to
exposure assessment of the different component, dose-response relationship and common
health metric and general framework for risk-benefit assessment.
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APPENDIX
1. The Relative Risks of CHD Mortality and Total Stroke
Tables 8 and 9 present the results of studies on the relation between fish intake and the
relative risks of CHD mortality and stroke. These results are used for dose response
modeling. The most appropriate model is selected after analysis from the five functions
mentioned below, based on best fit statistics using statistical computing R-programme.
 RR = a + b * Fintake
 RR = a + b * ln(Fintake)
 ln(RR) = a + b * Fintake
 ln(RR) = b * Fintake
 ln(RR) = a + b * ln(Fintake)
Where, RR is relative risk; a and b are parameters and Fintake, is fish intake per day (Dose).
Table 8. The studies incorporated in the dose-response modeling of CHD mortality:
fish intake (g/d) and relative risk (RR)
Reference Dose
(g/d)
RR (95% CI) Reference Dose
(g/d)
RR (95%CI)
Kromhout et al.,
1985
0 1 Mozaffarian et
al., 2003
0 1
7.5 0.63 7 0.78 (0.47, 1.28)
22.5 0.56 14 0.77 (0.45, 132)
37.5 0.36 29 0.53 (0.30, 0.96)
75 0.39 71 0.47 (0.27, 0.82)
Ascherio et al.,
1995
0 1 Mann et al.,
1997
0 1
7 0.74 (0.38, 1.45) 7 1.21(0.62, 2.38)
18 0.86 (0.5, 1.47) 29 1.23 (0.7, 2.17)
37 0.71 (0.41, 1.21) Oomen et al.,
2000, The
Netherlands
0 1
69 0.54 (0.29, 1.00 10 1 (0.59, 1.68)
119 0.77 (0.41, 1.44) 35 1.1 (0.68, 1.79)
Daviglus et al.,
1997
0 1 Oomen et al.,
2000, Finland
10 1
9 0.88 (0.63, 1.22) 30 0.97 (0.68, 1.38)
26 0.84 (0.61, 1.17) 70 1.25 (0.89, 1.76)
67.5 0.62 (0.4, 0.94) Jarvinen et al.
2006
4 1
Albert et al.,
1998
0 1 12·0 0.91 (0.55, 135)
7.5 1.18 (0.59, 2.26) 19.8 0.77 (0.48, 1.23)
21 0.82 (0.45, 1.51) 32 0.68 (0.42, 1.12)
50 0.91(0.5, 1.66) 70·0 0.59 (0.36, 0.99)
86 0.81(0.41, 1.61) Hu et al., 2002 0 1
Oomen et al.,
2000, Italy
0 1 7 0.8 (0.56, 1.15)
10 0.94 (0.55,1.59) 14 0.65 (0.46, 0.91)
30 0.93 (0.53, 1.63) 43 0.72 (0.48, 1.09)
70 0.67 (0.33, 1.39) 86 0.55 (0.33, 0.91)
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Table 9. The studies incorporated in the dose-response modeling of total stroke: Fish
intake (g/d) and relative risk (RR)
Reference Dose
(g/d)
RR (95% CI) Reference Dose
(g/d)
RR (95% CI)
He et al., 2002 0 1 Mozaffarian et al.,
2005)
0 1
7 0.73 (0.48-1.10) 7 0.88 (0.66–1.17)
14 0.74 (0.52-1.04 36 0.74 (0.56–0.98)
43 0.67 (0.46-0.96 86 0.77 (0.56–1.07)
86 0.83 (0.53-1.29) Orencia et al.,
1996
0 1
Iso et al., 2001 0 1 9 0.98 (0.61, 1.59)
7 0.93 (0.65-1.34) 26 0.94 (0.59, 1.52)
14 0.78 (0.55-1.12) 50 1.26 (0.74, 2.16)
43 0.73 (0.47-1.14 Larsson et al.,
2011
0 1
86 0.48 (0.21-1.06) 17 0.87 (0.75, 1.01)
Gillum et al.,
1996
0 1 25 0.92 (0.82, 1.09)
7 0.78 (0.54, 1.12) 36 0.88 (0.76, 1.02)
14 0.77 (0.53, 1.13) 64 0.84 (0.71, 0.98)
60 0.55 (0.32, 0.93) Wang et al., 2011 7 1
Gillum, et al.,
1996
0 1 29 0.7 (0.5, 0.98)
7 1.27 (0.83, 1.96) 80 0.82 (0.61, 1.11)
14 1.23 (0.79, 1.91)
60 0.85 (0.49, 1.46)
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Table 10. The model outputs for the relative risk of CHD mortality and stroke
Models CHD Stroke
RR= a + b* Fintake RR= 0.9-0.0028* Fintake
CI 95%: (0.79, 1.01) and (-0.005, -
0.0004)
p-value: (<0.001) and  (0.023)
RR= 0.935-0.0024*
Fintake
CI 95%: (0.82, 1.05) and
(-0.005, 0.0001)
p-value: (<0.001) and
(0.0593)
RR= a + b*ln(Fintake) RR= 1..11-0.0964*ln(Fintake)
CI 95%: (0.86, 1.36) and (-0.172, -
0.021)
p-value: (<0.001) and (0.014)
RR= 1.09-
0.075*ln(Fintake)
CI 95%: (0.83, 1.34) and
(-0.15, 0.003)
p-value: (<0.001) and
(0.059)
ln(RR)= a + b* Fintake ln(RR)= -0.13-0.004* Fintake
CI 95%: (-0.271, 0.02) and (-0.007, -
0.0008)
p-value: (0.081) and (0.016)
ln(RR)= -0.08-0.003
(Fintake)
CI 95%: (-0.21, 0.05)
and (-0.006, 0.0002)
p-value: (0.235, 0.038)
ln(RR)= b* Fintake ln(RR)= -0.006* Fintake
CI 95%: (-0.008, -0.0041)
p-value: <0.001
ln(RR): -0.0045* Fintake
CI 95%: (-0.006, -0.003)
p-value: <0.001
ln(RR)= a + b*ln (Fintake) ln(RR)= 0.17-0.137*ln (Fintake)
CI 95%: (-0.16, 0.5) and (-0.24, -
0.04)
p-value:(0.3) and (0.008)
ln(RR)= 0.113-0.094*ln
(Fintake)
CI 95%: (-0.184, 0.41)
and (-0.184, -0.004)
p-value: (0.44) and
(0.04)
The last model is used to estimate the relative risk for each scenario and endpoints.
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